MAM
AST

McCarthy Asset Management’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

McCarthy Asset Management’s Portfolio AST Stock Details AST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12
Closed – – 401
2021
Q2 		$0 Hold
12
– – ﹤0.01% 447
2021
Q1 		$0 Hold
12
– – ﹤0.01% 426
2020
Q4 		$0 Buy
+12
New – ﹤0.01% 380

McCarthy Asset Management's AST Position: Q3 2021 in Review

McCarthy Asset Management sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q3 2021, closing a stake of 12 shares.

McCarthy Asset Management first reported a position in AST in Q4 2020 and held it in 3 quarters. The position peaked at $0 in Q2 2021. 0 funds tracked by Wall St. Rank hold AST as of Q3 2021.

  • McCarthy Asset Management reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q3 2021 after selling out during the quarter.
  • McCarthy Asset Management sold 12 Asterias Biotherapeutics Inc. Series A shares in Q3 2021.
  • McCarthy Asset Management first reported a position in Asterias Biotherapeutics Inc. Series A in Q4 2020 and held it in 3 quarters.
  • McCarthy Asset Management's Asterias Biotherapeutics Inc. Series A position peaked at $0 in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q3 2021.

Based on McCarthy Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.